This article has been retracted: Aging has completed its investigation of this paper. We found multiple instances of image reuse and overlap with images from unrelated papers from different institutions. Specifically:
Figure 1:
The transwell assay image in Figure 1G is a reuse of image in Figure 4G from the authors earlier paper [1];
The control transwell assay image in Figure 1H was reused in Figure 2G of the authors 2021 paper [2], which is already retracted;
The control transwell assay image in Figure 1H overlaps with an unrelated image in Figure 5D from already retracted paper [3];
The images in Figure 1H, 1I overlap with the images in Figure 5B from earlier published unrelated paper [4];
Also, images in Figure 1I overlap with the images in Figures 4A and 5B from already retracted paper [5];
Additionally, the images in Figure 1I were found in Figure 3F from concurrently published paper [6].
Figure 4:
The transwell assay images in Figure 4A, 4B were found to overlap with images in Figure 4F of [1], Figure 4C of [4], Figure 4D of [5], and Figure 3C from [6].
The corresponding author informed us that these overlaps were due to improper data storage in the laboratory and has applied for a retraction. Given these findings, the Editorial decision was to retract the paper. All authors have agreed to this retraction.
References
- 1. Song Y, Guo B, Ma S, Chang P, Tao K. Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt. Biomed Pharmacother. 2018; 105:1291–8. https://doi.org/10.1016/j.biopha.2018.06.103 [PubMed]
- 2. Xu Y, Guo B, Liu X, Tao K. miR-34a inhibits melanoma growth by targeting ZEB1. Aging (Albany NY). 2021; 13:15538–47. https://doi.org/10.18632/aging.203114 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:13432–3. https://doi.org/10.18632/aging.206155 [PubMed]
- 3. Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer. Aging (Albany NY). 2019; 11:7780–95. https://doi.org/10.18632/aging.102286 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:12652–3. https://doi.org/10.18632/aging.206104 [PubMed]
- 4. Jiashi W, Chuang Q, Zhenjun Z, Guangbin W, Bin L, Ming H. MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Aging (Albany NY). 2018; 10:1294–305. https://doi.org/10.18632/aging.101468 [PubMed]
- 5. He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY). 2019; 11:5744–56. https://doi.org/10.18632/aging.102157 [PubMed] Retraction in: Aging (Albany NY). 2024; 16:12953–4. https://doi.org/10.18632/aging.206128 [PubMed]
- 6. Chen J, Yan C, Yu H, Zhen S, Yuan Q. miR-548d-3p inhibits osteosarcoma by downregulating KRAS. Aging (Albany NY). 2019; 11:5058–69. https://doi.org/10.18632/aging.102097 [PubMed]